v3.26.1
Accrued Expenses
12 Months Ended
Dec. 31, 2025
Accrued Expenses  
Accrued Expenses

Note 4.Accrued Expenses

The following is a summary of the Company’s accrued expenses:

​

​

​

​

​

​

​

​

​

​

December 31, 

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Clinical trial expenses

​

$

1,709,542

​

$

1,135,542

Other

​

 

272,088

​

 

1,223,797

Total

​

$

1,981,630

​

$

2,359,339

​